CHINA PHARMA HOLDINGS, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD, HAINAN PROVINCE, F4, 570216
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD, HAINAN PROVINCE, F4, 570216
Phone 8689866811730
Fiscal Year End 1231
EIN 731564807
Financial Overview
FY2024 FY
$4.53M
Revenue
$16.47M
Total Assets
$9.01M
Total Liabilities
$600K
Cash & Equivalents
$-0.27
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 10, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 8-K Current report of material events | December 10, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | November 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 14, 2025 | View on SEC |
| 8-K Current report of material events | April 4, 2025 | View on SEC |
Material Events
8-K Acquisition February 10, 2026
High Impact
- Strategic expansion into the gout treatment market and intellectual property portfolio.
- Acquisition of patent rights for 'Topiroxostat Nanoemulsion' with inventor's technical support.
8-K Strategy Change January 6, 2026
High Impact
- Shareholders approved a reverse stock split of up to 1-for-20 shares for CHINA PHARMA HOLDINGS, INC.
- New independent directors (Gene Michael Bennett, Yingwen Zhang, and Baowen Dong) were elected to the Board.
8-K Acquisition December 10, 2025
High Impact
- China Pharma Holdings, Inc. acquired patent rights for a Captopril microcapsule through its wholly-owned subsidiary.
- The acquisition was paid for with $6.3 million worth of company stock, involving the issuance of 3.5 million new shares.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.